Organization Profile

You just read:

Stiefel, a GSK company, enters into an agreement with Welichem Biotech, Inc. to acquire a novel topical agent for psoriasis and atopic dermatitis

News provided by

Welichem Biotech Inc.

May 30, 2012, 15:04 ET